# Becton Dickinson & Co: filings

BDX · NYSE · CIK 10795 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/bdx.md) · [Financials](/companies/bdx/financials.md) · [Filings](/companies/bdx/filings.md) · [Insiders](/companies/bdx/insiders.md)

## Reports and events: 343 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1147, 8-K 249, 3 62, 144 61, 424B2 56, 10-Q 54, SC 13G/A 40, 425 38, FWP 27, 11-K 26, DEFA14A 20, UPLOAD 20, CORRESP 19, 10-K 17, DEF 14A 16, SC 13G 15, 4/A 13, SD 13, 424B5 12, 25-NSE 11, 8-A12B 11, S-8 10, ARS 9, CERT 8, 5 7, S-3ASR 6, 3/A 5, 8-K/A 5, EFFECT 5, NO ACT 5, SCHEDULE 13G 5, 424B3 4, S-4 4, S-4/A 4, SCHEDULE 13G/A 4, CERTNYS 3, POSASR 3, S-8 POS 3, 10-K/A 2, DEFR14A 2, PRE 14A 2, 11-KT 1, POS AM 1, PX14A6G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:36 ET | [10-Q](/filings/0000010795-26-000035.md) | Quarterly report, period 2026-06-30 | 0000010795-26-000035 |
| 2026-08-06 | 06:31 ET | [8-K](/filings/0001628280-26-053790.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053790 |
| 2026-07-22 | 06:58 ET | [8-K](/filings/0001628280-26-049103.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-049103 |
| 2026-05-29 | 08:39 ET | [8-K](/filings/0001628280-26-039005.md) | 7.01 Regulation FD disclosure | 0001628280-26-039005 |
| 2026-05-20 | 17:05 ET | [8-K](/filings/0001140361-26-022270.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-022270 |
| 2026-05-12 | 16:30 ET | [8-K](/filings/0001140361-26-020828.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-020828 |
| 2026-05-07 | 16:34 ET | [10-Q](/filings/0000010795-26-000026.md) | Quarterly report, period 2026-03-31 | 0000010795-26-000026 |
| 2026-05-07 | 06:33 ET | [8-K/A](/filings/0001628280-26-031642.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031642 |
| 2026-05-07 | 06:30 ET | [8-K](/filings/0001628280-26-031638.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031638 |
| 2026-04-29 | 16:16 ET | [8-K](/filings/0000010795-26-000012.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-26-000012 |
| 2026-04-09 | 16:18 ET | [8-K](/filings/0001628280-26-024472.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-024472 |
| 2026-04-02 | 16:18 ET | [8-K](/filings/0001628280-26-023185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-023185 |
| 2026-02-25 | 16:25 ET | [8-K](/filings/0001140361-26-006794.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006794 |
| 2026-02-10 | 16:16 ET | [8-K](/filings/0001140361-26-004601.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-004601 |
| 2026-02-09 | 16:19 ET | [10-Q](/filings/0000010795-26-000005.md) | Quarterly report, period 2025-12-31 | 0000010795-26-000005 |
| 2026-02-09 | 16:18 ET | [8-K](/filings/0001193125-26-042827.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-042827 |
| 2026-02-09 | 06:31 ET | [8-K](/filings/0001628280-26-006182.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-006182 |
| 2026-02-05 | 16:21 ET | [8-K](/filings/0001193125-26-039448.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-039448 |
| 2026-02-05 | 16:17 ET | [8-K](/filings/0001628280-26-005793.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-005793 |
| 2026-01-30 | 16:17 ET | [8-K](/filings/0001628280-26-004393.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-004393 |
| 2026-01-06 | 16:45 ET | [8-K](/filings/0001193125-26-004659.md) | 5.04 Item not in the standard list | 0001193125-26-004659 |
| 2025-12-18 | 11:25 ET | [DEF 14A](/filings/0001628280-25-057846.md) | Proxy statement, period 2025-12-12 | 0001628280-25-057846 |
| 2025-12-01 | 16:18 ET | [8-K/A](/filings/0001628280-25-054447.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-054447 |
| 2025-11-25 | 16:27 ET | [10-K](/filings/0000010795-25-000099.md) | Annual report, period 2025-09-30 | 0000010795-25-000099 |
| 2025-11-17 | 16:34 ET | [8-K](/filings/0001628280-25-052625.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-052625 |
| 2025-11-06 | 06:32 ET | [8-K](/filings/0001628280-25-049835.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049835 |
| 2025-10-15 | 16:18 ET | [8-K](/filings/0001628280-25-045106.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-045106 |
| 2025-09-18 | 20:46 ET | [8-K](/filings/0001140361-25-035307.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-035307 |
| 2025-08-07 | 16:26 ET | [10-Q](/filings/0000010795-25-000072.md) | Quarterly report, period 2025-06-30 | 0000010795-25-000072 |
| 2025-08-07 | 06:33 ET | [8-K](/filings/0000010795-25-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-25-000069 |
| 2025-07-14 | 17:05 ET | [8-K](/filings/0001193125-25-158797.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-158797 |
| 2025-07-14 | 06:20 ET | [8-K](/filings/0001193125-25-158404.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-158404 |
| 2025-06-16 | 16:32 ET | [8-K](/filings/0000010795-25-000049.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-25-000049 |
| 2025-05-02 | 16:34 ET | [8-K](/filings/0000010795-25-000041.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-25-000041 |
| 2025-05-01 | 16:30 ET | [10-Q](/filings/0000010795-25-000039.md) | Quarterly report, period 2025-03-31 | 0000010795-25-000039 |
| 2025-05-01 | 06:32 ET | [8-K](/filings/0000010795-25-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-25-000036 |
| 2025-03-27 | 16:24 ET | [8-K](/filings/0000010795-25-000025.md) | 5.02 Departure or appointment of officers or directors | 0000010795-25-000025 |
| 2025-02-06 | 17:03 ET | [10-Q](/filings/0000010795-25-000022.md) | Quarterly report, period 2024-12-31 | 0000010795-25-000022 |
| 2025-02-05 | 16:32 ET | [8-K](/filings/0000010795-25-000019.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-25-000019 |
| 2025-01-31 | 16:06 ET | [8-K](/filings/0000010795-25-000011.md) | 5.07 Shareholder vote results | 0000010795-25-000011 |
| 2025-01-10 | 06:59 ET | [8-K](/filings/0000010795-25-000005.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-25-000005 |
| 2024-12-19 | 10:36 ET | [DEF 14A](/filings/0000010795-24-000096.md) | Proxy statement, period 2024-12-16 | 0000010795-24-000096 |
| 2024-11-27 | 13:36 ET | [10-K](/filings/0000010795-24-000084.md) | Annual report, period 2024-09-30 | 0000010795-24-000084 |
| 2024-11-07 | 06:37 ET | [8-K](/filings/0000010795-24-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-24-000078 |
| 2024-10-02 | 17:03 ET | [8-K](/filings/0000010795-24-000071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-24-000071 |
| 2024-08-30 | 16:16 ET | [8-K](/filings/0000950103-24-012970.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950103-24-012970 |
| 2024-08-01 | 16:33 ET | [10-Q](/filings/0000010795-24-000067.md) | Quarterly report, period 2024-06-30 | 0000010795-24-000067 |
| 2024-08-01 | 06:32 ET | [8-K](/filings/0000010795-24-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-24-000064 |
| 2024-07-12 | 06:01 ET | [8-K](/filings/0001140361-24-032969.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-032969 |
| 2024-06-07 | 17:04 ET | [8-K](/filings/0001140361-24-029309.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-029309 |

Page 1 of 7. [Older](/companies/bdx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 14:28 ET. No prices; not investment advice.